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Porcine reproductive and respiratory syndrome virus (PRRSV) suppresses tumor necrosis factor-alpha (TNFrx) production at both transcriptional and post-transcriptional levels by its non-structural proteins lrx and 1~
(Nsplrx and Nspl ~). To identifY the amino acid residues responsible for this activity, we generated several
alanine substitution mutants of Nsplrx and Nspl~. Examination of the mutant proteins revealed that Nsplrx
residues Gly90, Asn91 , Arg97, Argl 00 and Arg124 were necessary for TNF-rx promoter suppression, whereas
several amino acids spanning the entire Nspl ~ were found to be required for this activity. Two mutant
viruses, with mutations at Nsplrx Gly90 or Nspl~ residues 70-74, generated from infectious cDNA clones,
exhibited attenuated viral replication in vitro and TNF-rx was found to be up regulated in infected
macrophages. In infected pigs, the Nspl~ mutant virus was attenuated in growth. These studies provide
insights into how PRRSV evades the effector mechanisms of innate immunity dUling infection.
© 2012 Elsevier Inc. All rights reserved.
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Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV)
causes late-term abortion in sows and respiratory disease in
young pigs (Christianson et ai., 1993; Christianson et ai., 1992;
Rossow et ai., 1995). Following infection, PRRSV replicates in
lungs and secondary lymphoid tissues in the host and establishes
a viremic period of about 3-4 weeks (Duan, Nauwynck, and
Pensaert, 1997; Rossow et ai., 1994; Rossow et ai., 1995). The
viremic period is followed by a persistent period of 1-6 months,
characterized by low levels of virus replication in secondary lymphoid tissues (Allende et ai., 2000). The host immune response
usually takes several months to clear the virus from persistently
infected swine (Allende et ai., 2000).
Previous studies demonstrated that the adaptive immune
responses against PRRSV develop gradually, an important factor
in less efficient clearance of the virus from the host (Allende et ai.,
2000; Meier et ai., 2003). The ineffective adaptive immune
responses against PRRSV are the result of various immune evasion
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strategies utilized by this virus (Ansari et ai., 2006; Beura et ai.,
2010; Costers et aI., 2009; Lopez and Osorio, 2004; Ostrowski
et ai., 2002; Subramaniam et ai., 2010; Vu et ai., 2011). One such
strategy consists of inhibiting the key pro-inflammatory cytokine,
tumor necrosis factor-Cf (TNF-Cf) in infected cells (Lopez-Fuertes
et ai., 2000; Subramaniam et ai., 2010). The TNF-Cf response
against different PRRSV strains in pulmonary alveolar macrophages (PAMs) varies significantly depending on the strain
(Darwich et ai., 2011; Gimeno et ai., 2011). Since TNF-Cf can
inhibit PRRSV replication in macrophages (Lopez-Fuertes et ai.,
2000), we hypothesize that PRRSV-mediated TNF-Cf suppression
would likely enhance virus production in the infected host.
Our laboratory has previously shown that PRRSV-vFL12 strain
suppresses TNF-Cf during infection, at the promoter level and also
post-transcriptionally (Subramaniam et ai., 2010). Particularly,
vFL12 strain suppresses the TNF-Cf promoter only at early times
after infection. Even though TNF-Cf transcripts are abundant at
later time points after vFL12 infection, secreted TNF-Cf is not
detected in the infected culture supernatants (Subramaniam
et ai., 2010). The non-structural proteins 1Cf (NsplCf) and 1 ~
(Nsp1~) of the virus down-regulate NF-KB and Sp1 activities at
TNF-Cf promoter, respectively (Subramaniam et ai., 2010). In addition to Nsp1 proteins, PRRSV non-structural protein 2 (Nsp2) also
regulates TNF-Cf expression in infected cells (Chen et ai., 2010).
The variations in Nsp2 sequences account for differences in TNF-Cf
induction in response to various PRRSV field isolates (Darwich
et ai., 2011).
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Nsp1a and Nsp1b are non-structural proteins that participate
in various aspects of the PRRSV life cycle such as transcription,
virion biogenesis and innate immune evasion (Beura et al., 2010;
Kroese et al., 2008; Tijms et al., 2007). Nsp1a, the proteolytically
processed amino-terminal region of Nsp1, contains 180 amino
acid residues and forms two domains, an N-terminal zinc ﬁnger
domain (ZF domain) and a C-terminal papain-like cysteine protease (PCPa) domain (Sun et al., 2009). Nsp1b, the proteolytically
processed carboxy-terminal region of Nsp1, contains 203 amino
acid residues and forms three domains, an N-terminal nuclease
domain, a linker domain and a C-terminal papain-like cysteine
protease (PCPb) domain (Xue et al., 2010). The PCPa and PCPb
domains auto-cleave Nsp1a and Nsp1b from the viral polyprotein, respectively (Kroese et al., 2008). Upon cleavage and activation, both of these proteins homo-dimerize (Sun et al., 2009; Xue
et al., 2010). PCPa-mediated auto-cleavage of Nsp1a is essential
for transcription of viral sub-genomic RNAs (Kroese et al., 2008).
Likewise, PRRSV Nsp1a ZF domain may also directly participate in
viral transcription (Fang and Snijder, 2010; Tijms et al., 2007). On
the other hand, PCPb-mediated auto-cleavage of Nsp1b is essential for PRRSV replication (Kroese et al., 2008). In addition, the
Nsp1b nuclease domain cleaves double-stranded DNA, and singlestranded RNA in vitro (Xue et al., 2010). However, the Nsp1a
and Nsp1b sequences necessary for down-regulating the TNF-a
promoter activity are unknown.
In this study, we conducted mutagenesis studies to identify
the amino acid residues in Nsp1a and Nsp1b that are necessary
for affecting TNF-a promoter activity. Five Nsp1a amino acid
residues, Gly90, Asn91, Arg97, Arg100, and Arg124 were identiﬁed as required for suppression of TNF-a promoter activity.
Several Nsp1b amino acid residues spanning the entire protein
were found to be necessary for suppression of TNF-a promoter
activity. We subsequently recovered two mutant viruses from
infectious cDNA clones with alanine substitution at Nsp1a Gly90
residue or Nsp1b 70–74 amino acid positions. These mutant
viruses induced TNF-a mRNAs efﬁciently but induced protein
levels minimally in infected macrophages when compared to
the infection with wild type virus. In infected swine, the Nsp1b
mutant virus exhibited growth-attenuated phenotype as compared to the wild type virus. Overall, these results suggest the
possibility of generating attenuated PRRSVs for vaccine development through mutations in Nsp1b.

Results
Cysteine protease activities of Nsp1 are not necessary for TNF-a
promoter suppression
Nsp1a and Nsp1b cysteine protease activities are mediated by
PCPa and PCPb, respectively (Kroese et al., 2008). The histidine
residue at amino acid position 146 in vFL12-Nsp1a is a part of
PCPa active site as deduced by pairwise sequence alignment with
Nsp1a of Lelystad strain (Kroese et al., 2008). Similarly, the
cysteine residue at amino acid position 90 and the histidine
residue at amino acid position 159 of vFL12-Nsp1b are part of
the PCPb active site, as deduced by pairwise sequence alignment
with Nsp1b of Lelystad strain (Kroese et al., 2008). Mutation of
these residues to alanine in the expression constructs did not
affect their respective protein levels (Fig. 1A and B, bottom
panels). Transient reporter assays were carried out with a TNF-a
promoter-luciferase construct and lipopolysaccharide (LPS) was
used to stimulate the promoter. Both Nsp1a and Nsp1b mutated
in their respective cysteine protease active sites (PCPa and PCPb,
respectively) efﬁciently reduced the TNF-a promoter activity in
those assays when compared to their wild type counterparts

Fig. 1. PRRSV Nsp1a and Nsp1b suppress TNF-a promoter activity independently
of their cysteine protease functions. (A, B) RAW 264.7 cells were transfected with
pswTNF-luc plasmid (0.2 mg) along with indicated viral protein expressing
plasmid (1 mg) and a renilla luciferase-expressing vector (10 ng). After 24 h,
cells were stimulated with LPS (1 mg) for 6 h. In cell lysates, ﬁreﬂy luciferase
activities were measured and normalized with renilla luciferase activities. 100%
TNF-a promoter activity represents the activity in control vector transfected
cells and 0% promoter activity represents the activity in wild type Nsp1a or
Nsp1b transfected cells. Each bar represents mean 7 standard error (n ¼ 3).
Bottom panels depict the amount of corresponding viral proteins in transfected
cells. RAW 264.7 cells were transfected with viral protein expressing plasmid
(2 mg). After 24 h post-transfection, the viral protein in cell lysates was detected
by western blotting using anti-Nsp1 antibodies. b-actin was used as loading
control.

(Fig. 1A, B). The results suggest that Nsp1a and Nsp1b reduce the
TNF-a promoter activity independently of their cysteine protease
activities.

Identiﬁcation of Nsp1a amino acid residues critical for TNF-a
promoter suppression
Nsp1a has two distinct domains: the ZF domain (1–65 amino
acids) and the PCPa domain (66–166 amino acids) (Sun et al.,
2009). To identify which of these domains is necessary for
reducing TNF-a promoter activity, we performed alanine-scanning mutagenesis in randomly selected blocks of 4–6 amino acid
length spanning the entire Nsp1a protein. In transient reporter
assays, none of the PCPa domain mutants were able to reduce
TNF-a promoter activity (Fig. 2A). Certain PCPa domain mutants
such as Nsp1a122-6A, Nsp1a139-5A, and Nsp1a155-5A exhibited
reduced protein levels when compared to the wild type protein
(Fig. 2A). Three out of four ZF domain mutants (Nsp1a20-4A,
Nsp1a55-5A, and Nsp1a63-5A) reduced the TNF-a promoter
activity to similar extent as the wild type protein (Fig. 2A).
The remaining ZF domain mutant (Nsp1a41-5A) suppressed the
TNF-a promoter less efﬁciently than did the wild type protein,
which may be due to reduced protein expression (Fig. 2A). Three
amino acid scanning mutations in PCPa domain but not in the ZF
domain also relieved TNF-a promoter suppression (data not
shown). These results suggest that the PCPa domain but not ZF

S. Subramaniam et al. / Virology 432 (2012) 241–249

243

Fig. 2. Characterization of Nsp1a amino acid residues necessary for reducing TNF-a promoter activity. (A–C) RAW 264.7 cells were transfected with pswTNF-luc (0.2 mg)
along with Nsp1a wild type or mutant protein expressing plasmid (1 mg) and a renilla luciferase-expressing vector (10 ng). After 24 h, cells were stimulated with LPS (1 mg/
mL) for 6 h. Fireﬂy luciferase activities were measured in cell lysates and normalized with renilla luciferase activities. 100% TNF-a promoter activity represents the activity
in control vector transfected cells and 0% promoter activity represents the activity in wild type Nsp1a transfected cells. Each bar represents mean 7standard error (n ¼3).
The immunoblot panels depict the amount of corresponding viral proteins in transfected cells. RAW 264.7 cells were transfected with Nsp1a wild type or mutant protein
expressing plasmid (2 mg). After 24 h post-transfection, the viral protein in cell lysates was detected by western blotting using anti-Nsp1 antibodies. b-actin was used as
loading control. (D) Tertiary structure of Nsp1a. Residues necessary for reducing TNF-a promoter activity are highlighted: Three Arginine residues (in green), the Glycine
residue (in yellow) and the Asparagine residue (in blue). The ﬁgure was adopted from NCBI structure database (PDB ID: 3IFU) using Cn3D software. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)

domain appears to be primarily responsible for suppression of
TNF-a promoter activity.
Additional studies were performed to identify individual
amino acid residues in PCPa domain that are necessary for
reducing TNF-a promoter activity. Point mutations were introduced in selected amino acid stretches 89–93, 95–97, and 122–
127 of PCPa domain. Mutation of PCPa domain residues, Gly90,
Asn91, Arg97, Arg100, and Arg124 signiﬁcantly up regulated TNFa promoter activity when compared to the wild type protein
(Fig. 2B, C). Mutations of these amino acid residues did not affect
protein levels (Fig. 2B and C) or protease activities of Nsp1a (data
not shown). Examination of the Nsp1a tertiary structure revealed
that the amino acid residues, Gly90, Asn91, Arg97, Arg100, and
Arg124 are closely positioned on PCPa domain surface (Fig. 2D).
These studies suggest that the ﬁve amino acid residues in PCPa
domain, Gly90, Asn91, Arg97, Arg100, and Arg124 are important
for suppressing the TNF-a promoter activity.

Mutations in several Nsp1b amino acid stretches relieved TNF-a
promoter suppression
Nsp1b has three domains: an N-terminal nuclease domain
(1–48 amino acids), a ﬂexible linker domain (49–84 amino acids)
and a C-terminal PCPb domain (85–181 amino acids) (Xue et al.,
2010). To identify the domains involved in suppressing the TNF-a
promoter activity, alanine-scanning mutations of 4–6 amino acids
in all Nsp1b domains were introduced. In transient reporter
assays, most mutant proteins demonstrated relief of TNF-a
promoter suppression relative to the wild type protein (Fig. 3).
The mutant, Nsp1b101-5A suppressed TNF-a promoter moderately when compared to the wild type protein (Fig. 3). Although
the mutants, Nsp1b124-4A and Nsp1b136-5A, were expressed at
reduced protein levels when compared to the wild type protein
(Fig. 3), the relief of TNF-a promoter suppression activity was
signiﬁcant. The results suggest that all Nsp1b domains may be
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Table 1
Recovery of PRRSV mutant viruses by reverse genetics.
Amino acid positiona

Anti-N immunoﬂuorescence

Virus recovery

Nsp1a
Nsp1a
Nsp1a
Nsp1a
Nsp1a
Nsp1a
Nsp1a
Nsp1a
Nsp1a
Nsp1a
Nsp1b
Nsp1b





þ
þ




þ






þ
þ




þ


(89–93)
(95–97)
(97–100)
(122–127)
Gly90Ala
Gly90Ser
Asn91Ala
Arg97Ala
Arg100Ala
Arg124Ala
(70–74)
(113–118)

a
Number in the parentheses indicate the position of amino acids mutated to
alanines.

Fig. 3. All domains of Nsp1b contribute to TNF-a promoter suppression. RAW
264.7 cells were transfected with pswTNF-luc (0.2 mg) along with Nsp1b wild type
or mutant expressing plasmid (1 mg) and a renilla luciferase vector (10 ng). After
24 h, cells were stimulated with LPS (1 mg/mL) for 6 h. Fireﬂy luciferase activities
were measured in cell lysates and normalized with renilla luciferase activities.
100% TNF-a promoter activity represents the activity in control vector transfected
cells and 0% promoter activity represents the activity in wild type Nsp1b
transfected cells. Each bar represents mean 7 standard error (n¼ 3). Bottom panels
depict the amount of corresponding viral proteins in transfected cells. RAW 264.7
cells were transfected with Nsp1b wild type or mutant expressing plasmid (2 mg).
After 24 h post-transfection, the viral protein in cell lysates was detected by
western blotting using anti-Nsp1 antibodies. b-actin was used as loading control.

involved in inhibiting TNF-a promoter activity. Alternatively, it is
possible that mutations in some of these domains may have
affected the overall structure of the protein, thus rendering it
nonfunctional in its ability to suppress TNF-a promoter activity.
Recovery, growth kinetics and plaque morphology of Nsp1a
and Nsp1b mutant viruses
In the case of Nsp1a, attempts were made to recover viruses
harboring 3–6 amino acid block mutations from infectious cDNA
clones containing the mutations. Viruses with mutations at the
Nsp1a positions, 89–93, 95–97, 97–100, and 122–127 were nonviable as judged by the absence of anti-N (PRRSV nucleocapsid)
immunoﬂuorescence (Table 1) in cells infected with supernatants
from full-length viral RNA transfected cells. However, two viruses
(vFL12Nsp1aG90A and vFL12Nsp1aG90S) were recovered with
single point mutations at Nsp1a amino acid residue, Gly90
(Table 1). Viruses harboring other single point mutations at
Nsp1a amino acid residues, Asn91, Arg97, Arg100, and Arg124
were not viable (Table 1).
In the case of Nsp1b, attempts were made to generate viruses
with mutations at Nsp1b positions, 70–74 and 113–118. The
infectious virus was successfully recovered with mutations at
residues 70–74 (vFL12Nsp1b70-5A) but a viable virus could not

Fig. 4. Nsp1 mutant viruses have reduced growth when compared to wild type
vFL12 virus. (A) Multi-step growth kinetics in MARC-145 cells after infection with
0.1 m.o.i. of indicated viruses. Supernatant of infected cells was collected at
indicated time points and viral titration was performed in MARC-145 cells. Viral
titers are expressed as tissue culture infectivity dose50 (TCID50). Viral titer values
represent the mean 7 standard error (n¼ 3). (B) Plaque morphology of viruses in
MARC-145 cells. Cells were infected with FL12 wild type or mutant viruses,
covered with growth medium agar and incubated for 4 day. Cells were ﬁxed with
glutaraldehyde followed by crystal violet staining.

be recovered with mutation at residues 113–118 (Table 1). In an
attempt to recover a virus containing mutations in both Nsp1a
G90 and Nsp1b positions 70–74, we generated cDNA clones with
these mutations. However, repeated attempts to recover such a
virus were unsuccessful. Overall, we recovered three mutant
PRRSVs, two presenting mutations in Nsp1a at G90 (G90A,
G90S) and one with a mutation in Nsp1b at positions, 70–74. Of
the two Nsp1a mutant viruses, we used the virus with G90S
substitution for further studies, as this mutant virus contains two
nucleotide substitutions in this codon and is therefore less likely
to readily revert to the wild type sequence.
Multi-step growth kinetic analysis revealed that the mutant
viruses (vFL12Nsp1aG90S and vFL12Nsp1b70-5A) exhibited
overall similar growth kinetics as the parental wild type vFL12
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in MARC-145 cells. The vFL12Nsp1b70-5A virus grew slightly
slower than vFL12 virus exhibiting approximately a ten-fold
difference in titer (Fig. 4A). The vFL12Nsp1aG90S virus grew to
a titer that is approximately 5–7 fold less compared to vFL12
(Fig. 4A). Both mutant viruses also exhibited reduced plaque sizes
as compared to the wild type virus (Fig. 4B). Overall, these results
suggest that the mutant viruses, vFL12Nsp1aG90S and
vFL12Nsp1b70-5A, exhibit somewhat reduced growth in cultured
MARC-145 cells.
Expression of TNF-a in macrophages infected by Nsp1 mutant PRRSVs
is up regulated
Studies were performed to examine TNF-a responses after
infecting swine macrophages with vFL12 wild type or the mutant
viruses. Infections with Nsp1 mutant viruses induced higher levels
of TNF-a mRNAs only at 12 hpi when compared to the infection
with the wild type virus (Fig. 5A). Importantly, the mutant virus
vFL12Nsp1b70-5A induced signiﬁcant levels of TNF-a mRNA at the
early (12 hpi) time of infection (Fig. 5A). However, there were no
differences observed in TNF-a mRNA levels between wild type and
mutant virus infected macrophage cultures at 24 hpi (Fig. 5A). Our
additional experiments also showed that the Nsp1b70-5A mutant
protein did not affect Sp1-dependent transcriptional activities in
transient transfection assays (data not shown), which are necessary
for activating the TNF-a promoter (Falvo et al., 2000). The mutant
vFL12Nsp1aG90S virus induced higher levels of TNF-a protein in
the supernatant of infected macrophage cultures both at 12 and
24 hpi (Fig. 5B). However, both wild type vFL12 and mutant
vFL12Nsp1b70-5A viruses induced negligible levels of TNF-a protein
in the supernatant of infected macrophage cultures (Fig. 5B).
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Furthermore, the mutant viruses, replicated with low viral titers in
macrophage cultures after infection when compared to wild type
vFL12 (Fig. 5C). In particular, the mutant vFL12Nsp1b70-5A showed
an approximately 100-fold reduction in viral titers in macrophage
culture supernatants when compared to vFL12 (Fig. 5C).
Additionally, the macrophages infected with the mutant
viruses also induced higher mRNA levels of two pro-inﬂammatory
chemokines: CCL2 and CXCL10 at 24 and 36 h post-infection
when compared to macrophages infected with vFL12 (data not
shown). This is not unexpected considering that these two
chemokines are induced by TNF-a (Murao et al., 2000; Qi et al.,
2009). In summary, the two mutant viruses, vFL12Nsp1aG90S
and vFL12Nsp1b70-5A, stimulated the production of TNF-a
mRNA and protein more strongly than the wild type vFL12 in
infected macrophage cultures.
Growth attenuation and TNF-a induction phenotypes of PRRSV
mutant viruses in infected pigs
To examine the growth of the Nsp1 mutant viruses and TNF-a
responses in swine, pigs were infected with wild type vFL12 or the
mutant viruses. By 14 day post-infection (dpi), all infected pigs seroconverted (data not shown). In addition, all infected pigs exhibited
their peak viremia between 3 and 7 day post-infection (Fig. 6A, B).
Sequencing of viral RNAs isolated from serum until 14 day postinfection conﬁrmed the presence of Nsp1aG90S and Nsp1b70-5A
mutations in respective mutant viruses. When compared to wild
type vFL12, the mutant vFL12Nsp1b70-5A exhibited nearly two
log10 reduction in viral titers and viral RNA copies in serum at 3 dpi
(Fig. 6A, B). By 7 dpi, two out of three animals infected with the
mutant vFL12Nsp1b70-5A had no detectable infectious virus in

Fig. 5. TNF-a response against Nsp1 mutant viruses in infected primary macrophages in vitro. (A) Quantitative PCR analysis. PBMC-derived macrophages were mockinfected or infected with 0.1 m.o.i. of indicated viruses. At different time points, total RNAs were prepared from infected cells and cDNAs were synthesized. Using cDNAs as
template, the amount of TNF-a mRNAs was quantiﬁed by qPCR. TNF-a copy numbers were calculated using standard curve prepared with known amount of templates and
normalized with b-actin copy numbers. Bars represent mean 7standard error (n¼ 3). (B) TNF-a protein measurement by ELISA. PBMC-derived macrophages were infected
with vFL12 wild type or indicated mutant viruses at 0.1 m.o.i. TNF-a protein levels in the supernatant were measured by ELISA. Bars represent mean 7 standard error
(n¼ 3). Dotted line in y-axis represents the detection limit of assay. (C) Viral titers were measured in MARC-145 cells and expressed as TCID50/mL. Mean7 standard error
(n¼ 3) values were shown.
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Fig. 6. Comparison of viremia, TNF-a expression levels between pigs infected with vFL12 wild type and pigs infected with mutant viruses. Four-week old piglets (n¼ 3
each group) were infected intra-muscularly with 105.1TCID50 of vFL12 wild type or indicated mutant viruses. (A) Viral titers were evaluated in serum of infected pigs at
indicated time points after infection. Viral titration was done in MARC-145 cells. The viral titers were calculated by Reed and Muench method, and expressed as tissue
culture infectivity dose50 (TCID50/mL). Data indicate mean 7 standard error (n ¼3). (B) PRRSV-speciﬁc quantitative RT-PCR analysis. Viral RNAs were isolated from serum of
infected pigs at indicated time points after infection. They were quantiﬁed by qRT-PCR speciﬁc to vFL12 3’UTR as described in methods section. Viral RNA copies were
calculated by using a standard curve prepared with known amount of templates. Data indicate mean 7 standard error (n¼ 3). (C) TNF-a-speciﬁc qRT-PCR. Total RNAs were
isolated from 1  106 PBMCs collected from pigs at indicated time points after infection. TNF-a mRNA levels were quantiﬁed by qRT-PCR as described in methods section.
TNF-a mRNA copies were normalized with b-actin mRNA copies. Bars represent mean 7 standard error values (n¼ 3). (D) TNF-a ELISA. TNF-a protein levels in serum of
infected pigs were measured by ELISA at indicated time points after infection. Values are expressed as mean 7 standard error (n ¼3).

serum (Fig. 6A). However, viral RNAs were detected at lower levels
in pigs infected with the mutant vFL12Nsp1b70-5A when compared
to pigs infected with vFL12 for 14 dpi (Fig. 6B). In contrast, pigs
infected with the mutant vFL12Nsp1aG90S had similar viral titers
as well as viral RNA copies in serum when compared to the pigs
infected with vFL12 (Fig. 6A, B).
The TNF-a mRNA levels in PBMCs were enhanced in pigs infected
with vFL12Nsp1b70-5A virus at 3 dpi when compared to the wild
type vFL12 infection (Fig. 6C). Pigs infected with the mutant
vFL12Nsp1aG90S showed increased TNF-a protein levels in serum
at 7 dpi when compared to pigs infected with wild type vFL12
(Fig. 6D). However, at 10 dpi, both vFL12 and vFL12Nsp1aG90S
groups had similar elevated levels of TNF-a (Fig. 6D). In summary,
the mutant vFL12Nsp1b70-5A virus replicated with reduced viral
titers and the virus also up-regulated TNF-a mRNA levels at 3 dpi in
infected pigs.

Discussion
PRRSV decreases the production of TNF-a during infection
in vitro and in vivo (Calzada-Nova et al., 2011; Labarque et al.,
2003; Lopez-Fuertes et al., 2000; Subramaniam et al., 2010; van
Gucht, van Reeth, and Pensaert, 2003). Nsp1a and Nsp1b are
important viral mediators that reduce TNF-a promoter activity in
transient transfection assays (Subramaniam et al., 2010). In this
study, we identiﬁed critical amino acid residues in Nsp1a and
Nsp1b that are important for TNF-a down-regulation. Subsequently, through reverse genetics, we generated two mutant
PRRSV viruses that up-regulated TNF-a expression, particularly
at mRNA level in infected macrophage cultures. These two

mutant viruses replicated in cell culture with reduced viral titers.
In infected pigs, one mutant virus with mutation in Nsp1b
replicated with reduced viral titers in serum.
Several laboratories demonstrated that PRRSV infection leads to
poor TNF-a response in serum and broncho-alveolar lavage ﬂuid
from infected pigs (Labarque et al., 2003; Thanawongnuwech et al.,
2004; van Gucht, van Reeth, and Pensaert, 2003). Similarly, PRRSV
infection actively inhibits TNF-a expression in macrophages and
dendritic cells in vitro (Calzada-Nova et al. 2011; Lopez-Fuertes
et al., 2000). Previous results from our laboratory indicated that
PRRSV cysteine proteases, Nsp1a and Nsp1b suppress TNF-a
promoter by modulating the activity of speciﬁc transcription factors,
NF-kB and Sp1, respectively (Subramaniam et al., 2010). In this
study, we sought to further characterize the down-regulatory effect
by identifying the amino acid residues in Nsp1a and Nsp1b that
reduce TNF-a production. Upon such identiﬁcation, we pursued
recovering PRRSV strains with mutations in those positions by
reverse genetics and examining the mutants in infected animals
for their ability to relieve TNF-a suppression.
A previous study had shown that active site mutations in Nsp1
cysteine proteases lead to failure of virus recovery by reverse
genetics (Kroese et al., 2008). Our result showed that the Nsp1
cysteine protease activities were not necessary for suppressing
TNF-a promoter activity. This observation is consistent with
previous ﬁndings that the Nsp1 cysteine proteases cleave only
cis-substrates present at the end of respective proteins (Sun et al.,
2009; Xue et al., 2010). Therefore, it is less likely that Nsp1
cysteine protease activities degrade signaling molecules required
for the TNF-a-induction pathway.
Screening of domain-speciﬁc mutations in Nsp1a revealed
that the PCPa domain, but not the ZF domain, was primarily
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important for inhibiting TNF-a promoter activity. Five amino acid
residues (Gly90, Asn91, Arg97, Arg100, and Arg124) on the surface of the PCPa domain were important for inhibiting the TNF-a
promoter. Many mutations in the ZF domain of Nsp1a did not
signiﬁcantly relieve TNF-a suppression, which suggested that the
ZF domain may not directly participate in inhibiting the TNF-a
promoter activity. We were only able to recover mutant viruses
with mutations at Nsp1a Gly90 residue. However, viruses with
mutations at Nsp1a residues Asn91, Arg97, Arg100, and Arg124,
were not viable, though they were found to be dispensable for
PCPa protease activity. These amino acid residues may be
important for other Nsp1a functions, such as viral transcription,
replication and/or virion biogenesis (Fang and Snijder, 2010).
Unlike Nsp1a, all three domains of Nsp1b seem to be important for down regulating TNF-a promoter activity. One of Nsp1b
mutant (70-5A) exhibits protein levels equivalent to wild type but
did not reduce TNF-a promoter activity efﬁciently. In agreement
with this, 70-5A mutant protein did not also reduce transcription
driven by Sp1, which bind TNF-a promoter to activate transcription (Falvo et al., 2000). The 70-5A mutation is located in a small
linker domain of Nsp1b. The successful recovery of mutant virus
in this position suggests that the amino acids at 70–74 position
are not required for Nsp1b protease activity over Nsp1b–Nsp2
junction. It seems plausible that the Nsp1b linker domain may
directly participate in the inhibition of Sp1 trans-activation or
indirectly modulate the functions of the other Nsp1b domains to
inhibit Sp1-dependent TNF-a transcription.
Previous studies demonstrated that PRRSV suppresses TNF-a
expression at the transcriptional and post-transcriptional levels
(Subramaniam et al., 2010; Thanawongnuwech et al., 2004). PRRSV
particularly inhibited the TNF-a transcription during early time
points after infection in macrophages (Subramaniam et al., 2010).
We conﬁrmed such previous ﬁnding in the present study. Both Nsp1
mutant virus infections showed enhanced TNF-a transcriptional
activity at early times (12 h) post-infection. Particularly, the Nsp1b
mutant virus signiﬁcantly induced TNF-a mRNA levels at 12 h postinfection in infected macrophage cultures. In consistent with these
in vitro observations, pigs infected with Nsp1b mutant virus also
up-regulated TNF-a mRNA levels at 3 dpi in peripheral blood
mononuclear cells.
When the growth characteristics of Nsp1 mutant viruses were
examined, both viruses were moderately attenuated in growth in
susceptible MARC-145 cells, which may be due to the effects in
other Nsp1 functions such as transcription and replication. When
we examined the growth of these mutant viruses in macrophages
in vitro and in infected pigs, the growth of vFL12Nsp1b70-5A was
severely compromised but the growth of vFL12Nsp1aG90S was
affected to a minimal level. Even though vFL12Nsp1b70-5A
mutant virus has ability to induce TNF-a mRNAs earlier than
the wild type virus, it did not induce signiﬁcant TNF-a protein at
any time point after infection in vitro or in vivo. Hence, the
crippled growth of vFL12Nsp1b70-5A in macrophages in vitro
and in infected pigs is more likely due to loss of some other
critical function of the protein important for viral progression.
The vFL12Nsp1aG90S mutant virus infection produced detectable levels of TNF-a protein in macrophages when compared to
wild type virus infection. This suggests that in addition to its
effect at the promoter level, Nsp1a also inhibits TNF-a production
via a post-transcriptional mechanism. This is evident in animal
studies in which vFL12Nsp1aG90S mutant virus induced TNF-a in
serum of infected pigs at 7 dpi when compared to wild type vFL12
infected pigs. Additional experiments also revealed that, when
over-expressed, Nsp1a reduces co-expressing TNF-a protein
levels without affecting Internal Ribosome Entry Site (IRES)dependent GFP expressed from a bi-cistronic mRNA. Further, in
those experiments, Nsp1aG90S mutant protein did not efﬁciently
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reduce TNF-a protein levels expressed from the bi-cistronic
construct when compared to the wild type protein.
In summary, the overall conclusions of this study are: (1) Nsp1a
amino acid residue Gly90 is necessary for suppressing the TNF-a
promoter activity and TNF-a protein levels during PRRSV infection;
(2) Nsp1b amino acid residues at 70–74 are necessary for suppressing the TNF-a promoter activity; and (3) PRRSV-vFL12 strain with
mutation at Nsp1b positions 70–74 produced signiﬁcantly reduced
viral titers in infected pigs, an information that may pave the way
for new candidate attenuated live vaccines.

Materials and methods
Cells and viruses
RAW 264.7 cells, a murine macrophage cell line (ATCC) was
maintained in RPMI-1640 supplemented with 10% fetal bovine
serum (FBS). MARC-145 cells, an African green monkey kidney
epithelial cell line (obtained from Dr. Will Laegreid, University of
Illinois, Urbana-Champaign) was maintained in Dulbecco’s modiﬁed eagle medium (DMEM)-low glucose supplemented with 10%
FBS. BHK-21, baby hamster kidney epithelial cell line (ATCC)
was maintained in DMEM-high glucose supplemented with 10%
FBS. Primary swine macrophages were prepared from PBMCs as
previously described (Subramaniam et al., 2010). PRRSV vFL12
strain (GenBank ID: AY545985) and its mutant viruses were
propagated and titrated in MARC-145 cells. Viral titers were
calculated using the Reed and Muench method (Reed and
Muench, 1938). Viral plaque assays were performed in MARC145 cells as previously described (Ansari et al., 2006).
TNF-a promoter-luciferase reporter assay
Swine TNF-a promoter-luciferase reporter assay was carried
out as previously described (Subramaniam et al., 2010). RAW
264.7 cells were co-transfected with plasmids, pswTNF-luc (0.2 mg)
(Subramaniam et al., 2010) and pRL-TK (10 ng) (Promega), and wild
type or mutant Nsp1a/Nsp1b-expressing plasmid (1 mg) using
DEAE-dextran (Sigma) by following a procedure described earlier
(Subramaniam et al., 2010). After 24 h of transfection, the reporter
genes were stimulated with LPS (1 mg/mL) for 6 h. Fireﬂy and renilla
luciferase activities were measured using dual luciferase reporter
assay system in GloMax 20/20 luminometer (Promega). Fireﬂy
luciferase units were normalized with renilla luciferase units.
Relative luciferase units were calculated by dividing normalized
ﬁreﬂy luciferase units measured from stimulated cells with those
measured from unstimulated cells.
Plasmids construction
pIHA-Nsp1D268–297 plasmid was constructed by deleting
thirty amino acids from 268 to 297 amino acid positions in the
whole Nsp1 sequence (Gene Bank Accession No. AY545985).
Plasmids expressing Nsp1a or Nsp1b (pIHA-Nsp1a and pIHANsp1b (Subramaniam et al., 2010)) were used to introduce 3–6
amino acid alanine-scanning mutations. pIHA-Nsp1D268–297
plasmid was used to introduce point mutations in Nsp1a. Mutations were introduced into Nsp1 genes by PCR mutagenesis
following the mega primer method (Sarkar and Sommer, 1990).
In order to transfer Nsp1a and Nsp1b mutant sequences from
pIHA constructs into pFL12 infectious clone (Truong et al., 2004),
we constructed an intermediate transfer vector pIHA-2757. The
plasmid was constructed by cloning RsrII and SpeI restrictiondigested fragment of pFL12 infectious clone into pIHA empty
vector (Beura et al., 2010). Nsp1a mutant sequences were cloned
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into pIHA-2757 using AccI and StuI restriction sites present within
Nsp1a. Nsp1b mutant sequences were cloned into pIHA-2757
using AvrII and BsrGI restriction sites present within Nsp1b.
Finally, the RsrII and SpeI digested fragment was transferred from
the pIHA-2757 mutant plasmid into pFL12 infectious clone. The
corresponding mutation in pFL12 plasmid was conﬁrmed by
sequencing.

Quantitative RT-PCR and ELISA
TNF-a-speciﬁc quantitative PCR (qPCR) was performed as
previously described (Subramaniam et al., 2010). Brieﬂy, total
RNA fractions were prepared from mock-infected cells or cells
infected with either vFL12 or mutant viruses using Trizol-LS
reagent (Invitrogen). Complementary DNAs (cDNAs) were synthesized using oligo-dTs as primer. cDNAs were used as template in
qPCR reactions to measure TNF-a or b-actin mRNAs using
sequence-speciﬁc primers and probes (Subramaniam et al., 2010).
PRRSV 30 untranslated region (UTR)-speciﬁc qRT-PCR was performed to detect viral RNAs in serum of infected pigs. Brieﬂy, viral
RNAs were isolated from 140 mL of serum using QIAamp viral
RNA mini kit (Qiagen). Viral RNAs (4 mL) were used as template
in quantitative reverse-transcription (RT)-PCR reaction using hot
start-IT Probe one step qRT-PCR kit (USB, 75772). The following
primers and probe were used in the reaction: forward primer
ATGTGTGGTGAATGGCACTG, reverse primer GCATGGTTCTCGCCAATTAAA, Taqman probe 6-FAM-TCACCTATTCAATTAGGGCGACCGTAMRA. The cycling conditions employed were as follows: reverse
J
J
transcription at 50 C for 30 min, initial enzyme activation at 95 C
for 2 min, denaturation at 95 JC for 15 s followed by annealing/
J
extension at 60 C for 60 s. Denaturation and annealing/extension
steps were repeated for total of 45 cycles.
To measure the TNF-a protein levels in the supernatant of
mock-infected or virus-infected cells, a commercial swine TNF-aspeciﬁc ELISA was used (Pierce/Invitrogen).

Western blotting
Cellular protein lysates were prepared in either radio-immunoprecipitation assay buffer or cell-lysis buffer as described elsewhere
(Alcaraz et al., 1990; Beura et al., 2010). Equal amounts of total
protein were resolved in 12% Sodium dodecyl Sulfate (SDS)-polyacrylamide gel electrophoresis and transferred on Polyvinylidene
ﬂuoride (PVDF) membrane. The membrane was blotted with rabbit
polyclonal antibodies speciﬁc for Nsp1 or mouse monoclonal antiJ
bodies speciﬁc for b-actin (Santacruz) for overnight at 4 C. The
membranes were treated with Horse Radish Peroxidase (HRP)conjugated anti-rabbit or anti-mouse IgG antibodies (KPL) for 1 h
at RT and signals were obtained with chemiluminescence substrates
(Thermo scientiﬁc).

In vitro transcription, electroporation and recovery of mutant viruses
Capped in vitro transcripts (IVTs) were prepared from wild type
or mutant pFL12 infectious clones as previously described (Kwon
et al., 2006; Truong et al., 2004). IVTs were electroporated into
MARC-145 or BHK-21 cells by following a procedure described
earlier (Ansari et al., 2006). After 1–2 day post-electroporation, the
replication of mutant virus was conﬁrmed by immunoﬂuorescence
using anti-N monoclonal antibodies (SDOW17, NVSL-USDA). The
success of viral recovery was assessed by spread of cytopathic effect
in electroporated MARC-145 cells. The supernatants from electroporated BHK-21 cells were transferred on to PBMC-derived macrophages to propagate recovered viruses.

Viral growth kinetics and in vitro infection studies
For multi-step growth kinetics, MARC-145 cells were cultured
in 96-well plates two days before infection. On the third day, cells
were infected with vFL12 wild type or mutant viruses at 0.1 multiplicity of infection (m.o.i.) in triplicates. At 6, 12, 24, 48, 72, 96 h
post-infection, supernatants were collected and viruses were
titrated in MARC-145 cells. The viral titers were calculated using
Reed and Muench method (Reed and Muench, 1938). For measuring TNF-a mRNA and protein responses in vitro, PBMC-derived
macrophages were infected with vFL12 wild type or mutant
viruses at 0.1 m.o.i. At 12, 24, 36 and 48 h post-infection, cells
were collected in Trizol-LS (Invitrogen) for mRNA quantiﬁcation.
Supernatants were collected to measure TNF-a protein and viral
titers.
Animal experiments
Four-week old PRRSV-negative pigs (n ¼3 each group) were
infected with vFL12 wild type or mutant strains at 105.1 TCID50/
2 mL intra-muscularly. At 3, 7, 10, 14, 21 day post-infection (dpi),
serum was collected to determine viremia and TNF-a protein
levels by viral titration and ELISA, respectively. Similarly, PBMCs
(1  106 cells/aliquot) were collected in Trizol-LS for mRNA
quantiﬁcation.
Statistical analysis
The signiﬁcance in difference between means of two treatment
groups was tested using one-tailed unpaired student’s t-test. A ‘p’
value of less than 0.05 was considered signiﬁcant. Analyses were
performed using Prism 5 (Graphpad).
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